Concordia College in Moorhead is conducting a study that aims to explore how medications and lifestyle choices affect brain health in adults aged 55 to 70. The focus is on those who are overweight or taking anti-obesity medications like semaglutide and liraglutide.
Led by registered dietitian nutritionist Betsy Cogan, the study will look into the potential cognitive benefits of GLP-1 receptor agonist medications. Cogan noted that while these medications show promise for weight loss and other health improvements, their impact on cognitive function is still uncertain.
Participants will go through a variety of assessments, including body measurements, blood tests, and cognitive evaluations. They will also track their physical activity and diet for three days. In return, they will receive beneficial health insights, such as information on body composition, blood pressure, and dietary habits.
This study aligns with recent trends in health research. For instance, a recent survey by the American Psychological Association found that managing weight can significantly enhance mental well-being in older adults. Furthermore, studies indicate that maintaining a healthy weight can reduce the risk of cognitive decline.
Potential participants can reach out to Betsy Cogan at ecogan@cord.edu or call 218-299-3644 for more details. Participation is voluntary, and individuals can withdraw at any time.
Source link
concordia college,dietary research,nutrition,obesity drugs